A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines

BACKGROUND: Multiple myeloma is a plasma-cell tumor with heterogeneity in molecular abnormalities and treatment response. DESIGN AND METHODS: We have assessed whether human myeloma cell lines have kept patients’ heterogeneity using Affymetrix gene expression profiling of 40 human myeloma cell lines...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Moreaux, Jérôme, Klein, Bernard, Bataille, Régis, Descamps, Géraldine, Maïga, Sophie, Hose, Dirk, Goldschmidt, Hartmut, Jauch, Anna, Rème, Thierry, Jourdan, Michel, Amiot, Martine, Pellat-Deceunynck, Catherine
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3069235/
https://ncbi.nlm.nih.gov/pubmed/21173094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.033456
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados